Agency Forms Undergoing Paperwork Reduction Act Review, 11419-11420 [E6-3190]
Download as PDF
<![CDATA[
11419
Federal Register / Vol. 71, No. 44 / Tuesday, March 7, 2006 / Notices
records. Mothers of case and control
infants are interviewed using a
computer-assisted telephone interview.
Parents are asked to collect cheek cells
from themselves and their infants for
DNA testing. Information gathered from
both the interviews and the DNA
specimens will be used to study
independent genetic and environmental
factors as well as gene-environment
interactions for a broad range of
carefully classified birth defects.
The program is requesting approval
for an additional three years. There is no
cost to the respondent other than their
time. The total estimated annualized
burden hours are 600.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Instrument
NBDPS case/control interview .....................................................................................................
Biologic specimen collection ........................................................................................................
Dated: February 27, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–3189 Filed 3–6–06; 8:45 am]
BILLING CODE 4163–18–P
Proposed Project
National Exposure Registry—
Extension—(OMB No. 0923–0006)—
Agency for Toxic Substances and
Disease Registry (ATSDR)—Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-06–0006]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
ATSDR is mandated pursuant to the
1980 Comprehensive Environmental
Response Compensation and Liability
Act (CERCLA) and its 1986
Amendments, the Superfund
Amendments and Re-authorization Act
(SARA), to establish and maintain a
national registry of persons who have
been exposed to hazardous substances
in the environment and a national
registry of persons with illnesses or
health problems resulting from such
exposure. In 1988, ATSDR created the
National Exposure Registry (NER) as a
result of this legislation in an effort to
provide scientific information about
potential adverse health effects people
develop as a result of low-level, longterm exposure to hazardous substances.
The NER is a program which collects,
maintains, and analyzes information
obtained from participants (called
registrants) whose exposure to selected
toxic substances at specific geographic
Frequency of
response
400
1,200
1
1
Average burden/response
(in hours)
1
10/60
areas in the United States has been
documented. Relevant health data and
demographic information are also
included in the NER databases. The
NER databases furnish the information
needed to generate appropriate and
valid hypotheses for future activities
such as epidemiologic studies. The NER
also serves as a mechanism for
longitudinal health investigations that
follow registrants over time to ascertain
adverse health effects and latency
periods.
Participants in each subregistry are
interviewed initially with a baseline
questionnaire. An identical follow-up
telephone questionnaire is administered
to participants every three years until
the criteria for terminating a specific
subregistry have been met. The annual
number of participants varies greatly
from year to year. Two factors
influencing the number of respondents
per year are the number of subregistry
updates that are scheduled and whether
a new subregistry will be established.
There is no cost to the respondents
other than their time. The total
estimated annualized burden hours are
834.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses
Responses
per
respondent
Average
burden per
response
(in hours)
NER Registrant ............................................................................................................................
sroberts on PROD1PC70 with NOTICES
Respondents
1,667
1
30/60
VerDate Aug<31>2005
16:39 Mar 06, 2006
Jkt 208001
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
E:\FR\FM\07MRN1.SGM
07MRN1
11420
Federal Register / Vol. 71, No. 44 / Tuesday, March 7, 2006 / Notices
Dated: February 27, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–3190 Filed 3–6–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Privacy Act of 1974; Report of a
Modified or Altered System of Records
Department of Health and
Human Services (HHS), Centers for
Medicare & Medicaid Services (CMS).
ACTION: Notice of a Modified or Altered
System of Records (SOR).
sroberts on PROD1PC70 with NOTICES
AGENCY:
SUMMARY: In accordance with the
requirements of the Privacy Act of 1974,
we are proposing to modify or alter an
existing SOR, ‘‘Medicare Beneficiary
Database (MBD),’’ System No. 09–70–
0536. This system was last published at
66 FR 63392 (December 6, 2001). The
initial stage of development of the MBD
contained data of interest to the
Medicare Managed Care program. Since
publication of the notice in 2001, all
proposed phases of development for this
system have been completed. We
propose to broaden the scope of this
system to collect and maintain data
elements necessary for the new
voluntary prescription drug benefit
program required by Section 101 of the
Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 (MMA) (Pub. L. 108–173). This
new prescription drug benefit program
was enacted into law on December 8,
2003, and amended Title XVIII of the
Social Security Act (the Act). The
regulations establishing the new
Medicare ‘‘Part D’’ Prescription Drug
Benefit program are codified at Title 42
of the Code of Federal Regulations
(CFR), Parts 403, 411, 417 and 423.
Although the database has always
contained the entire Medicare
beneficiary population, the broadened
scope of this modification will
document the completion of the
following phases: Phase II completed
the development of data elements of
interest to the Medicare Fee-For-Service
Program; Phase III incorporated data
elements necessary to implement the
Medicare prescription drug discount
card program; and Phase IV will
complete the development of the MBD
to include all provisions mandated by
the MMA.
To more accurately reflect the
information maintained in this system
VerDate Aug<31>2005
16:39 Mar 06, 2006
Jkt 208001
we will change any reference to the
program under Part C of Title XVIII
currently referred to as the
‘‘Medicare+Choice Program’’ to read the
‘‘Medicare Advantage (MA) Program.’’
The MA Program shall consist of the
program under Part C of Title XVIII of
the Act, to include MA and MA–PD.
Information maintained in this system
related to the MA and MA–PD shall be
derived from the Medicare Advantage
Prescription Drug System (MARx)
(formerly known as the ‘‘Medicare
Managed Care System (MMCS)) System
No. 09–70–4001.
Generally, coverage for the
prescription drug benefit under Part D
will be provided under PDPs, which
will offer only prescription drug
coverage. Under Part C, Medicare
Managed Care Organizations will offer
prescription drug coverage that is
integrated with the health care coverage
they provide to beneficiaries and will be
referred to as Part C of the Medicare
Program.
The broadened scope of the Part D
benefit will include the following
activities; (1) determination of the status
of Medicare beneficiaries who are
eligible for the Low Income Subsidy
Program (LIS) and are deemed to receive
certain drug benefits; and (2) autoassignment/auto-enrollment of
beneficiaries as required by the MMA,
to include all LIS and deemed
individuals who are not voluntarily
enrolled in a drug plan, will
automatically be assigned to a
Prescription Drug Plan (PDP) or
Medicare Advantage (MA) Prescription
Drug Plan (MA–PD). Information will be
received from state organizations and
from the Social Security Administration
(SSA) and the MBD will make the final
determination as to the status of the
beneficiary.
We propose to modify existing routine
use number 1 that permits disclosure to
agency contractors and consultants to
include grantees who perform a task for
the agency. The modified routine use
will remain as routine use number 1.
We will also modify existing routine use
number 5 to change the name from Peer
Review Organizations to read Quality
Improvement Organizations (QIO) and
to reflect requirements established for
QIOs related to the Medicare Part D
Program. The modified routine use will
remain as routine use number 5. We
further propose to modify published
routine use number 6 that permits
disclosure to other insurers. We will
expand the stated requirements related
to coordination of benefits for the
Medicare program, to implement the
Medicare Secondary Payer (MSP)
provisions, and to clarify CMS’’ policy
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
on disclosure of privacy protected data
elements maintained in this system. The
modified routine use will remain as
routine use number 6.
We will modify the language in the
remaining routine uses to provide
clarity to CMS’s intention to disclose
individual-specific information
contained in this system. The routine
uses will then be prioritized and
reordered according to their proposed
usage. We will also take the opportunity
to update any sections of the system that
were affected by recent reorganizations
and to update language in the
administrative sections to correspond
with language used in other CMS SORs.
The primary purpose of this modified
system is to provide CMS with a
singular, authoritative, database of
comprehensive data on individuals in
the Medicare program to support
ongoing and expanded program
administration, service delivery
modalities, and payment coverage
options. This collection will contain a
complete ‘‘beneficiary insurance
profile’’ that reflects the individual
Medicare and Medicaid health
insurance coverage and Medicare health
plan and demonstration enrollment.
This system will also included data
necessary to process certain activities
associated with the new Medicare
prescription drug benefit program.
Information retrieved from this system
of records will also be disclosed to: (1)
Support regulatory, reimbursement, and
policy functions performed within the
agency or by a contractor, consultant or
grantee; (2) assist another Federal or
state agency, agency of a state
government, an agency established by
state law, or its fiscal agent; (3) support
providers and suppliers of services for
administration of Title XVIII; (4) assist
third parties where the contact is
expected to have information relating to
the individual’s capacity to manage his
or her own affairs; (5) support Quality
Improvement Organizations (QIO); (6)
assist other insurers for processing
individual insurance claims; (7)
facilitate research on the quality and
effectiveness of care provided, as well as
payment related projects; (8) support
constituent requests made to a
congressional representative; (9) support
litigation involving the agency; and (10)
combat fraud and abuse in certain
health benefits programs. We have
provided background information about
the modified system in the
SUPPLEMENTARY INFORMATION section
below. Although the Privacy Act
requires only that CMS provide an
opportunity for interested persons to
comment on the routine uses, CMS
invites comments on all portions of this
E:\FR\FM\07MRN1.SGM
07MRN1
]]>Agencies
[Federal Register Volume 71, Number 44 (Tuesday, March 7, 2006)]
[Notices]
[Pages 11419-11420]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-3190]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-06-0006]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Proposed Project
National Exposure Registry--Extension--(OMB No. 0923-0006)--Agency
for Toxic Substances and Disease Registry (ATSDR)--Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
ATSDR is mandated pursuant to the 1980 Comprehensive Environmental
Response Compensation and Liability Act (CERCLA) and its 1986
Amendments, the Superfund Amendments and Re-authorization Act (SARA),
to establish and maintain a national registry of persons who have been
exposed to hazardous substances in the environment and a national
registry of persons with illnesses or health problems resulting from
such exposure. In 1988, ATSDR created the National Exposure Registry
(NER) as a result of this legislation in an effort to provide
scientific information about potential adverse health effects people
develop as a result of low-level, long-term exposure to hazardous
substances.
The NER is a program which collects, maintains, and analyzes
information obtained from participants (called registrants) whose
exposure to selected toxic substances at specific geographic areas in
the United States has been documented. Relevant health data and
demographic information are also included in the NER databases. The NER
databases furnish the information needed to generate appropriate and
valid hypotheses for future activities such as epidemiologic studies.
The NER also serves as a mechanism for longitudinal health
investigations that follow registrants over time to ascertain adverse
health effects and latency periods.
Participants in each subregistry are interviewed initially with a
baseline questionnaire. An identical follow-up telephone questionnaire
is administered to participants every three years until the criteria
for terminating a specific subregistry have been met. The annual number
of participants varies greatly from year to year. Two factors
influencing the number of respondents per year are the number of
subregistry updates that are scheduled and whether a new subregistry
will be established. There is no cost to the respondents other than
their time. The total estimated annualized burden hours are 834.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average burden
Respondents Number of Responses per per response
responses respondent (in hours)
----------------------------------------------------------------------------------------------------------------
NER Registrant............................................... 1,667 1 30/60
----------------------------------------------------------------------------------------------------------------
[[Page 11420]]
Dated: February 27, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-3190 Filed 3-6-06; 8:45 am]
BILLING CODE 4163-18-P
